Jeong Hyun Ha1, Ki Yong Hong2, Han-Byoel Lee3, Hyeong-Gon Moon4, Wonshik Han3,4, Dong-Young Noh3,4, Joonho Lim1, Sehoon Yoon1, Hak Chang1,5, Ung Sik Jin6,7. 1. Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul, South Korea. 2. Department of Plastic and Reconstructive Surgery, Dongguk University Medical Center, Goyang, South Korea. 3. Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea. 4. Cancer Research Institute, Seoul National University, Seoul, South Korea. 5. Department of Plastic and Reconstructive Surgery, Seoul National University College of Medicine, Seoul, South Korea. 6. Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul, South Korea. usj1011@snu.ac.kr. 7. Department of Plastic and Reconstructive Surgery, Seoul National University College of Medicine, Seoul, South Korea. usj1011@snu.ac.kr.
Abstract
BACKGROUND: Although immediate breast reconstruction has been reported to be oncologically safe, no affirmative study comparing the two reconstruction methods exists. We investigated breast cancer recurrence rates in two breast reconstruction types; implant reconstruction and autologous flap reconstruction. METHODS: A retrospective cohort study was performed on propensity score-matched (for age, stage, estrogen receptor status) patients who underwent IBR after mastectomy at Seoul National University Hospital between 2010 and 2014. The main outcomes determined were locoregional recurrence-free interval (LRRFI) and disease-free interval (DFI). RESULTS: We analyzed 496 patients among 731 patients following propensity score matching (Median age 43, 247 implant reconstruction and 249 flap reconstruction). During median follow-up of 58.2 months, DFI was not different between the two groups at each tumor stage. However, flap reconstruction showed inferior DFI compared to implant reconstruction in patients with high histologic grade (p = 0.012), and with high Ki-67 (p = 0.028). Flap reconstruction was related to short DFI in multivariate analysis in aggressive tumor subsets. Short DFI after flap reconstruction in aggressive tumor cell phenotype was most evident in hormone positive/Her-2 negative cancer (p = 0.008). LRRFI, on the other hand, did not show difference according to reconstruction method regardless of tumor cell aggressiveness. CONCLUSION: Although there is no difference in cancer recurrence according to reconstruction method in general, flap-based reconstruction showed higher systemic recurrence associated with histologically aggressive tumors.
BACKGROUND: Although immediate breast reconstruction has been reported to be oncologically safe, no affirmative study comparing the two reconstruction methods exists. We investigated breast cancer recurrence rates in two breast reconstruction types; implant reconstruction and autologous flap reconstruction. METHODS: A retrospective cohort study was performed on propensity score-matched (for age, stage, estrogen receptor status) patients who underwent IBR after mastectomy at Seoul National University Hospital between 2010 and 2014. The main outcomes determined were locoregional recurrence-free interval (LRRFI) and disease-free interval (DFI). RESULTS: We analyzed 496 patients among 731 patients following propensity score matching (Median age 43, 247 implant reconstruction and 249 flap reconstruction). During median follow-up of 58.2 months, DFI was not different between the two groups at each tumor stage. However, flap reconstruction showed inferior DFI compared to implant reconstruction in patients with high histologic grade (p = 0.012), and with high Ki-67 (p = 0.028). Flap reconstruction was related to short DFI in multivariate analysis in aggressive tumor subsets. Short DFI after flap reconstruction in aggressive tumor cell phenotype was most evident in hormone positive/Her-2 negative cancer (p = 0.008). LRRFI, on the other hand, did not show difference according to reconstruction method regardless of tumor cell aggressiveness. CONCLUSION: Although there is no difference in cancer recurrence according to reconstruction method in general, flap-based reconstruction showed higher systemic recurrence associated with histologically aggressive tumors.
Entities:
Keywords:
Breast neoplasm; Breast reconstruction; Flap; Implant; Oncologic safety
Authors: Zhen-Yu Wu; Hyun Ho Han; Hee Jeong Kim; Jong Won Lee; Il Yong Chung; Jisun Kim; Sae Byul Lee; Byung-Ho Son; Jin Sup Eom; Jae Ho Jung; Sung- Bae Kim; Gyungyub Gong; Hak Hee Kim; Sei -Hyun Ahn; BeomSeok Ko Journal: Breast Cancer Res Treat Date: 2021-03-19 Impact factor: 4.872
Authors: Nalee Kim; Haeyoung Kim; Won Park; Doo Ho Choi; Won Kyung Cho; Seok Jin Nam; Jeong Eon Lee; Seok Won Kim; Jonghan Yu; Sei Kyung Lee; Byung-Joon Jeon; Jai Kyong Pyon; Goo-Hyun Mun; Tae Gyu Kim Journal: Breast Cancer Res Treat Date: 2022-01-16 Impact factor: 4.872
Authors: Justin M Broyles; Ethan M Balk; Gaelen P Adam; Wangnan Cao; Monika Reddy Bhuma; Shivani Mehta; Laura S Dominici; Andrea L Pusic; Ian J Saldanha Journal: Plast Reconstr Surg Glob Open Date: 2022-03-11
Authors: Claudia A Bargon; Danny A Young-Afat; Mehmet Ikinci; Assa Braakenburg; Hinne A Rakhorst; Marc A M Mureau; Helena M Verkooijen; Annemiek Doeksen Journal: Cancer Date: 2022-07-27 Impact factor: 6.921
Authors: Christina M Dudley; Alyssa A Wiener; Trista J Stankowski-Drengler; Jessica R Schumacher; Amanda B Francescatti; Samuel O Poore; Caprice C Greenberg; Heather B Neuman Journal: Clin Breast Cancer Date: 2021-03-27 Impact factor: 3.078